UPDATE: Ebola vaccine webinar series

21 August 2026 | Vaccines

The Vaccines and Emerging Infections Subcommittees present a three-part webinar series to explore the evidence, development and implementation of vaccines for Bundibugyo ebolavirus disease.

Through expert presentations and facilitated discussion, participants will examine emerging data on cross-protection, advances in clinical development, and the practical challenges of vaccine deployment, providing timely context ahead of the October SAGE meeting on Ebola vaccines.

Save the date for the webinars below. More information on the programme and links to register will be coming soon!

Evidence of cross-protection against BDBV following vaccination against Zaire ebolavirus

Date: Wednesday, 16 September 2026

Programme

Chairs: Krutika Kuppalli & TBD

14:00–14:05 Introduction
14:05–14:15 Epidemiologic and outbreak overview
- Speaker: Boris Pavlin (WHO)
14:15–14:35 Scientific evidence for cross-protection
- Speaker: Beth-Ann Coller
14:35–14:50 WHO SAGE perspective
- Speaker: Annelies Wilder-Smith (London School of Hygiene and Tropical Medicine, UK)
14:50–15:05 Evaluation of Ervebo: MSF perspective
- Speaker: TBD
15:05–15:20 DRC Plans for evaluating Ervebo: Ministry of Health/Africa CDC perspective
- Speaker: TBD
15:20–15:30 Q&A

The BDBV vaccine development pipeline: from early development to phase 2/3 evaluation

Date: Wednesday, 30 September 2026

Registration: Coming soon

From licensure to impact: implementing BDBV vaccination programmes

Date: Wednesday, 14 October 2026

Registration: Coming soon